Valuation: PolyPeptide Group AG

Market Cap 1.54B 1.75B 1.46B 1.31B 2.48B 167B 2.51B 17.42B 6.7B 85.54B 6.55B 6.41B 274B P/E 2026 *
48.9x
P/E 2027 * 29.5x
Enterprise Value 1.65B 1.87B 1.56B 1.41B 2.66B 180B 2.69B 18.69B 7.19B 91.78B 7.03B 6.88B 294B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 2.93x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.14%
1 day-0.06%
1 week-0.11%
1 month+0.23%
3 months-8.60%
6 months+48.48%
Current year+68.97%
1 week 44.05
Extreme 44.05
44.2
1 month 43.95
Extreme 43.95
44.25
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-0.06%-0.11%+85.29%+158.35% 1.75B
-2.33%+0.53%+51.65%+115.42% 1,031B
-1.06%-1.65%+42.78%+69.98% 638B
-0.65%-1.32%+12.98%+75.49% 462B
-2.66%-1.87%+73.13%+41.15% 359B
-0.60%-4.49%+22.95%+39.93% 335B
-1.64%-0.76%+13.50%+26.44% 273B
-1.93%-2.95%-3.23%+9.90% 253B
-0.50%+3.80%+49.37%+56.84% 228B
-1.47%-1.53%+34.28%+98.89% 185B
Average -0.48%-0.35%+38.27%+69.24% 376.56B
Weighted average by Cap. -0.31%-0.35%+37.46%+71.15%

Financials

2026 *2027 *
Net sales 498M 565M 471M 426M 802M 54.17B 812M 5.64B 2.17B 27.7B 2.12B 2.08B 88.79B 574M 651M 544M 491M 925M 62.46B 937M 6.5B 2.5B 31.93B 2.45B 2.39B 102B
Net income 25M 28.39M 23.69M 21.38M 40.3M 2.72B 40.82M 283M 109M 1.39B 107M 104M 4.46B 45M 51.1M 42.64M 38.49M 72.55M 4.9B 73.48M 510M 196M 2.5B 192M 188M 8.03B
Net Debt 112M 127M 106M 95.8M 181M 12.19B 183M 1.27B 489M 6.23B 478M 467M 19.99B 146M 166M 138M 125M 235M 15.9B 238M 1.66B 637M 8.13B 623M 609M 26.06B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
26-10-01 CHF 44.10 0.00% 10,977
26-09-30 CHF 44.10 +0.11% 84,898
26-09-29 CHF 44.05 -0.11% 23,228
26-09-28 CHF 44.10 0.00% 30,768
26-09-25 CHF 44.10 -0.11% 45,501
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
46.55EUR
Average target price
42.12EUR
Spread / Average Target
-9.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock